MWAETC and IDEA in Washington is currently hiring. Position: Financial Operations Specialist - MWAETC & IDEAClick here for details
Review of studies on HIV prevention, treatment and co-morbidities…
Update on treatment guidelines, new agents, and what's in the pipeline
When and how to initiate treatment and establish care for patients newly…
Best practices for linking, engaging, and retaining youth with HIV (YWH)…
The "how to" of using Cabotegravir/Rilpivirine in your clinic
Review of HIV treatment studies presented at the CROI 2022 conference
Overview of the ART decision-making tool, ASSIST
Update on 2021 DHHS HIV treatment guidelines
Interactions between ART medications for HIV and DAA medications for…
How to integrate long-acting injectable ART into the clinical care setting
Overview of Fostemsavir, a recently approved attachment inhibitor
Dr. Landovitz discusses HPTN 083, an efficacy study of long-acting…
2020 CROI highlights on Dual ART and HIV Cure progress
2020 CROI highlights on ART safety and side effects
Update on 2019 DHHS gudielines on 2-Drug and other initial ART regimens
Update on 2019 DHHS treatment guidelines for adults and adolescents
Empty Subtitle Byline for this Presentation. Need to enter byline.
Overview of long-acting injectable Cabotegravir plus Rilpirivine as ART